These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27005718)

  • 21. Counterfeit and substandard drugs in India may be smaller problem than claimed, say government findings.
    Travasso C
    BMJ; 2014 Jan; 348():g60. PubMed ID: 25489932
    [No Abstract]   [Full Text] [Related]  

  • 22. Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.
    't Hoen E; Pascual F
    J Public Health Policy; 2015 Nov; 36(4):384-9. PubMed ID: 26178809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries.
    Poudel RS; Shrestha S; Thapa S; Poudel BK; Chhetri M
    J Pharm Policy Pract; 2018; 11():13. PubMed ID: 29930813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bad medicine. Monitoring programs target substandard drugs.
    Grens K
    Mod Healthc; 2013 May; 43(20):30-1. PubMed ID: 23947275
    [No Abstract]   [Full Text] [Related]  

  • 25. Medicines counterfeiting is a complex problem: a review of key challenges across the supply chain.
    Tremblay M
    Curr Drug Saf; 2013 Feb; 8(1):43-55. PubMed ID: 23656447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the drug quality and safety net.
    Carter A
    J Diabetes Sci Technol; 2014 Jul; 8(4):898-9. PubMed ID: 24876419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs, drugs--who has the drugs?
    Blair J
    J Healthc Prot Manage; 2012; 28(1):28-32. PubMed ID: 22423518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health risks of counterfeit pharmaceuticals.
    ten Ham M
    Drug Saf; 2003; 26(14):991-7. PubMed ID: 14583061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding and fighting the medicine counterfeit market.
    Dégardin K; Roggo Y; Margot P
    J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equivalence in Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available in Nigeria (EQUIMEDS): A Case for Further Surveillance.
    Redfern J; Kaur H; Adedoyin RA; Ofori S; Anchala R; Vamadevan AS; De Andrade L; Zelaya J; Balabanova D; Sani MU
    Glob Heart; 2019 Sep; 14(3):327-333. PubMed ID: 31451241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies.
    Taylor RB; Shakoor O; Behrens RH; Everard M; Low AS; Wangboonskul J; Reid RG; Kolawole JA
    Lancet; 2001 Jun; 357(9272):1933-6. PubMed ID: 11425415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of Medicines in Portugal: A Retrospective Review of Medicine Recalls (2000-2015).
    Machado Reis AT; Berardo BFR; Loureiro R
    PDA J Pharm Sci Technol; 2018; 72(1):44-49. PubMed ID: 29030530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interchangeability between paracetamol tablets marketed in Palestine. Is there a quality reason for a higher price?
    Zaid A; Rinno T; Jaradat N; Jodeh S; Khammash S
    East Mediterr Health J; 2013 Jun; 19(6):542-6. PubMed ID: 24975183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Are there counterfeit medicines in Croatia?].
    Tomić S; Milcić N; Sokolić M; Sucić AF; Martinac AI
    Lijec Vjesn; 2010; 132(3-4):81-6. PubMed ID: 20540433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Counterfeit drugs and medical devices in developing countries.
    Glass BD
    Res Rep Trop Med; 2014; 5():11-22. PubMed ID: 32669888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-malarial drug quality in Lagos and Accra - a comparison of various quality assessments.
    Bate R; Hess K
    Malar J; 2010 Jun; 9():157. PubMed ID: 20537190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health risks related to illegal and on-line sale of drugs and food supplements: results of a survey on marketed products in Italy from 2011 to 2013.
    Gaudiano MC; Manna L; Bartolomei M; Rodomonte AL; Bertocchi P; Antoniella E; Romanini L; Alimonti S; Rufini L; Valvo L
    Ann Ist Super Sanita; 2016; 52(1):128-32. PubMed ID: 27033629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.